These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26992707)

  • 41. Capsule Commentary on Raghavan et al., Incident Type 2 Diabetes Risk is Influenced by Obesity and Diabetes in Social Contacts: A Social Network Analysis.
    Kandula NR
    J Gen Intern Med; 2016 Oct; 31(10):1212. PubMed ID: 27473007
    [No Abstract]   [Full Text] [Related]  

  • 42. Capsule commentary on Lynch et al., Geographic and racial/ethnic variations in patterns of multimorbidity burden in patients with type 2 diabetes.
    Adepoju O
    J Gen Intern Med; 2015 Jan; 30(1):93. PubMed ID: 25361684
    [No Abstract]   [Full Text] [Related]  

  • 43. Residual confounding in the study by van Dalem et al.
    Landman GWD; Kleefstra N; van Hateren KJJ
    Diabetes Obes Metab; 2018 Jun; 20(6):1547-1548. PubMed ID: 29493108
    [No Abstract]   [Full Text] [Related]  

  • 44. Capsule Commentary on Woodfine et. al., Criteria for Hyponatremic Overcorrection: Systematic Review and Cohort Study of Emergently Ill Patients.
    McAlister E; McAlister FA
    J Gen Intern Med; 2020 Jan; 35(1):405. PubMed ID: 31637646
    [No Abstract]   [Full Text] [Related]  

  • 45. Capsule Commentary on Franklin et al., Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA.
    Gamble JM
    J Gen Intern Med; 2018 Nov; 33(11):1955. PubMed ID: 30187375
    [No Abstract]   [Full Text] [Related]  

  • 46. Commentary on "Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force".
    Singh SK
    Indian J Endocrinol Metab; 2018; 22(1):158-159. PubMed ID: 29535953
    [No Abstract]   [Full Text] [Related]  

  • 47. Capsule Commentary on Correa et al., Assessing the Effect of Clinical Inertia on Diabetes Outcomes: a Modeling Approach.
    Smith PC
    J Gen Intern Med; 2019 Mar; 34(3):443. PubMed ID: 30610576
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of non-insulin-dependent diabetes mellitus with metformin.
    Guthrie R
    J Am Board Fam Pract; 1997; 10(3):213-21. PubMed ID: 9159660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Capsule Commentary on Min et al., Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes: How to Escalate Therapy for Patients who Fail Sulfonylureas.
    Chatterjee R; Edelman D
    J Gen Intern Med; 2016 Jun; 31(6):650. PubMed ID: 26992707
    [No Abstract]   [Full Text] [Related]  

  • 50. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
    Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
    Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.
    Hamid Z; Simmons DL
    Diabetes Care; 2006 Oct; 29(10):2331; author reply 2332. PubMed ID: 17003324
    [No Abstract]   [Full Text] [Related]  

  • 52. Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes.
    Orkaby AR; Cho K; Cormack J; Gagnon DR; Driver JA
    Neurology; 2017 Oct; 89(18):1877-1885. PubMed ID: 28954880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes.
    Min JY; Griffin MR; Hung AM; Grijalva CG; Greevy RA; Liu X; Elasy T; Roumie CL
    J Gen Intern Med; 2016 Jun; 31(6):638-46. PubMed ID: 26921160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetes Care; 2015 Jan; 38(1):140-9. PubMed ID: 25538310
    [No Abstract]   [Full Text] [Related]  

  • 55. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.
    Prentice JC; Conlin PR; Gellad WF; Edelman D; Lee TA; Pizer SD
    Value Health; 2014 Dec; 17(8):854-62. PubMed ID: 25498781
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.